These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17999841)

  • 1. Drug-eluting stents: a systematic review and economic evaluation.
    Hill RA; Boland A; Dickson R; Dündar Y; Haycox A; McLeod C; Mujica Mota R; Walley T; Bagust A
    Health Technol Assess; 2007 Nov; 11(46):iii, xi-221. PubMed ID: 17999841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery stents: a rapid systematic review and economic evaluation.
    Hill R; Bagust A; Bakhai A; Dickson R; Dündar Y; Haycox A; Mujica Mota R; Reaney A; Roberts D; Williamson P; Walley T
    Health Technol Assess; 2004 Sep; 8(35):iii-iv, 1-242. PubMed ID: 15361315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.
    Greenhalgh J; Hockenhull J; Rao N; Dundar Y; Dickson RC; Bagust A
    Cochrane Database Syst Rev; 2010 May; (5):CD004587. PubMed ID: 20464732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
    Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
    Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
    Ferko N; Ferrante G; Hasegawa JT; Schikorr T; Soleas IM; Hernandez JB; Sabaté M; Kaiser C; Brugaletta S; de la Torre Hernandez JM; Galatius S; Cequier A; Eberli F; de Belder A; Serruys PW; Valgimigli M
    Catheter Cardiovasc Interv; 2017 May; 89(6):994-1002. PubMed ID: 27527508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analyses of drug eluting stents versus bare metal stents: a systematic review of the literature.
    Neyt M; Van Brabandt H; Devriese S; De Laet C
    Health Policy; 2009 Jul; 91(2):107-20. PubMed ID: 19135756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can PCI with drug-eluting stents replace coronary artery bypass surgery? A comparative economic analysis regarding both therapeutic options based on clinical 12-month data reflecting the German social health care insurance system].
    Fricke FU; Silber S
    Herz; 2005 Jun; 30(4):332-8. PubMed ID: 15965811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
    Varani E; Guastaroba P; Di Tanna GL; Saia F; Balducelli M; Campo G; Vignali L; Rossi R; Manari A; Piovaccari G; De Palma R; Marzocchi A
    EuroIntervention; 2010 Apr; 5(8):953-61. PubMed ID: 20542781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic evaluation of drug-eluting stents: a systematic literature review and model-based cost-utility analysis.
    Kuukasjärvi P; Räsänen P; Malmivaara A; Aronen P; Sintonen H
    Int J Technol Assess Health Care; 2007; 23(4):473-9. PubMed ID: 17937836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.
    Katsanos K; Geisler BP; Garner AM; Zayed H; Cleveland T; Pietzsch JB
    BMJ Open; 2016 May; 6(5):e011245. PubMed ID: 27160845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
    Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
    Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.
    Ariyaratne TV; Yap CH; Ademi Z; Rosenfeldt F; Duffy SJ; Billah B; Reid CM
    Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):261-270. PubMed ID: 29474722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, humanistic, and economic outcomes between drug-eluting stent (DES) and bare metal stent (BMS): 18-month follow-up study.
    Lee VW; Cheng FW; Choi AY; Fong ST; Yu CM; Yan BP
    J Med Econ; 2017 Mar; 20(3):239-245. PubMed ID: 27737596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study.
    Rodriguez AE; Maree A; Tarragona S; Fernandez-Pereira C; Santaera O; Rodriguez Granillo AM; Rodriguez-Granillo GA; Russo-Felssen M; Kukreja N; Antoniucci D; Palacios IF; Serruys PW;
    EuroIntervention; 2009 Jun; 5(2):255-64. PubMed ID: 20449934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].
    Silber S; Herdeg C
    Herz; 2008 Apr; 33(3):196-205. PubMed ID: 18568314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trial.
    Rodriguez AE; Rodriguez-Granillo AM; Antoniucci D; Mieres J; Fernandez-Pereira C; Rodriguez-Granillo GA; Santaera O; Rubilar B; Palacios IF; Serruys PW;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):385-94. PubMed ID: 22109997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
    Philip F; Stewart S; Southard JA
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):38-48. PubMed ID: 26916633
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.